CAS No.:141396-28-3
Name: Argatroban
Details Introduction
TOXICITY DATA with REFERENCE：
| Organism | Test Type | Route | Reported Dose (Normalized Dose) | Effect | Source |
|---|---|---|---|---|---|
| mouse | LD50 | intraperitoneal | 475mg/kg (475mg/kg) | BEHAVIORAL: SOMNOLENCE (GENERAL DEPRESSED ACTIVITY) LUNGS, THORAX, OR RESPIRATION: DYSPNEA BLOOD: NORMOCYTIC ANEMIA |
Yakuri to Chiryo. Pharmacology and Therapeutics. Vol. 14(Suppl, |
| mouse | LD50 | intravenous | > 81mg/kg (81mg/kg) | BLOOD: HEMORRHAGE | Yakuri to Chiryo. Pharmacology and Therapeutics. Vol. 14(Suppl, |
| mouse | LD50 | oral | > 15gm/kg (15000mg/kg) | BLOOD: HEMORRHAGE BLOOD: NORMOCYTIC ANEMIA |
Yakuri to Chiryo. Pharmacology and Therapeutics. Vol. 14(Suppl, |
| mouse | LD50 | subcutaneous | 3750mg/kg (3750mg/kg) | BEHAVIORAL: SOMNOLENCE (GENERAL DEPRESSED ACTIVITY) BLOOD: NORMOCYTIC ANEMIA SKIN AND APPENDAGES (SKIN): "DERMATITIS, OTHER: AFTER SYSTEMIC EXPOSURE" |
Yakuri to Chiryo. Pharmacology and Therapeutics. Vol. 14(Suppl, |
| rat | LD50 | intraperitoneal | 320mg/kg (320mg/kg) | SENSE ORGANS AND SPECIAL SENSES: PTOSIS: EYE BEHAVIORAL: SOMNOLENCE (GENERAL DEPRESSED ACTIVITY) BLOOD: NORMOCYTIC ANEMIA |
Yakuri to Chiryo. Pharmacology and Therapeutics. Vol. 14(Suppl, |
| rat | LD50 | intravenous | > 81mg/kg (81mg/kg) | BLOOD: HEMORRHAGE | Yakuri to Chiryo. Pharmacology and Therapeutics. Vol. 14(Suppl, |
| rat | LD50 | oral | > 15gm/kg (15000mg/kg) | BLOOD: HEMORRHAGE BLOOD: NORMOCYTIC ANEMIA |
Yakuri to Chiryo. Pharmacology and Therapeutics. Vol. 14(Suppl, |
| rat | LD50 | subcutaneous | 620mg/kg (620mg/kg) | LUNGS, THORAX, OR RESPIRATION: DYSPNEA BLOOD: NORMOCYTIC ANEMIA SKIN AND APPENDAGES (SKIN): "DERMATITIS, OTHER: AFTER SYSTEMIC EXPOSURE" |
Yakuri to Chiryo. Pharmacology and Therapeutics. Vol. 14(Suppl, |
Consensus Reports：
SAFETY PROFILE：
Standards and Recommendations：
Analytical Methods：
Related Searches
Related Suppliers
- Chemvon Biotechnology Co. Ltd.
- BrightGene Bio-Medical Technology Co., Ltd.
- Shanghai Forever Synthesis Co.,Ltd.
- Watson International Ltd
- Synasia Inc
- LGM Pharma
- Chemieliva Pharmaceutical Co., Ltd.
- NANJING BOLD CHEMICAL CO.,LTD
- HANGZHOU FOREWIN PHARMA CO., LTD
- Lundbeck Pharmaceuticals
- Enaltec Labs Pvt. Ltd.
- hangzhou minko chemical co。，ltd
- SIHONG BONA INDUSTRY AND TRADE CO.,LTD.
- Shaanxi King Stone Enterprise Company Limited
- Suzhou unite pharmtech co.,ltd.
- SHANGHAI ARCADIA BIOTECHNOLOGY LTD.
- Nanjing MSNCHEM Co.,Ltd.
- Chengdu Sino-Strong Pharmaceutical Co.,Ltd.
- Wuhan Benjamin Pharmaceutical Chemical Co.,Ltd
- asynderm pharm co .,ltd
Other Product
- -
- -
- -
- -
- -
- -
- -
- -
- -
- (4S,6R)-6-{2-[(2-hydroxy-ethyl)-(4-methoxy-benzenesulfonyl)-amino]-ethoxy}-4-isopropyl-5,6-dihydro-4H-pyran-2-carboxylic acid allyl ester
- [1,4'-Bipiperidine]-1'-carboxylic acid, 4-(1H-indol-7-yl)-, ethyl ester
- 1,3,5-Tris(4-acetamidophenyl)penta-1,5-dione
- 1,5-Bis(3-aminophenyl)-3-(4-N,N-di-methylaminophenyl)penta-1,5-dione
- 1,5-Bis(4-acetamidophenyl)-3-phenylpenta-1,5-dione
- 1,5-Bis(4-aminophenyl)-3-(4-acetamido-phenyl)penta-1,5-dione
- 1,5-Bis(4-aminophenyl)-3-phenylpenta-1,5-dione